Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 7 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Société d'Exploration et de Traitements Endocriniens et Gynécologiques from Ans, company number BE0438767721, closed financial year 2025 with a result of € 14,683 after tax. For that financial year Société d'Exploration et de Traitements Endocriniens et Gynécologiques recorded a gross margin of € 79,526 and equity of € 779,774. Compared with financial year 2024, the result moved from € 12,368 to € 14,683. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 25, 2026.
€ 779,774
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 14,683
▲ 19% vs 2024
Profit after tax over the fiscal year.
€ 20,532
▼ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 773,577.
People and assets in 2025
€ 4,796
▼ 7% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 12
Loans from banks and other lenders, long and short.
€ 2,514
▼ 51% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 146,966 | € 108,560 | € 79,633 | € 79,526 | |
| Profit after taxes | € 47,466 | € 29,257 | € 12,368 | € 14,683 | ▲ 19% |
| Equity | € 723,466 | € 752,723 | € 765,091 | € 779,774 | ▲ 2% |
| Total debts | € 463,080 | € 412,753 | € 356,639 | € 313,760 | ▼ 12% |
| Cash | € 7,321 | € 17,818 | € 20,863 | € 20,532 | ▼ 2% |
| Land & buildings | € 1,120,667 | € 1,079,317 | € 1,038,544 | € 1,001,442 | ▼ 4% |
| Retained profit | € 717,269 | € 746,526 | € 758,894 | € 773,577 | ▲ 2% |
| Bank debt | € 37,006 | € 15,628 | € 0 | € 12 | |
| Balance sheet total | € 1,186,545 | € 1,165,476 | € 1,121,730 | € 1,093,534 | ▼ 3% |
Key figures of Société d'Exploration et de Traitements Endocriniens et Gynécologiques, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Société d'Exploration et de Traitements Endocriniens et Gynécologiques?
What happened at Société d'Exploration et de Traitements Endocriniens et Gynécologiques in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jean-Paul Renwart stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 14,683 (▲ 19% vs 2024). Source: NBB ↗
- Jean-Paul Renwart became a director. NBB
- New establishment in Ans. KBO
- Start of the company according to the CBE. KBO
In short
From € 47,466 profit in 2022 to € 14,683 profit in 2025.
Paid € 55,555 in corporate taxes since 2022.
Best year ever: 2022, with € 47,466 profit.
Management
Directors
According to the 2025 annual accounts
Jean-Paul Renwart
Director
since 2014 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue Edouard Colson 59
4431 Ans
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0438.767.721
- VAT number
- BE 0438.767.721
- Registered office
- Rue Edouard Colson 59, 4431 Ans
- Names & denominations
- Société d'Exploration et de Traitements Endocriniens et Gynécologiques · E.T.E.G.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 November 1989
- Peppol
- Not registered
- Contact
- [email protected] 04/263.40.96